| Product Name | MF | CAS | Details |
|---|
| Bayer-18 | C19H27FN6O2 | 1251752-12-1 | Details |
| BEZ235 | C30H23N5O | 915019-65-7 | Details |
| BI-2536 | C28H39N7O3 | 755038-02-9 | Details |
| BI-D1870 | C19H23F2N5O2 | 501437-28-1 | Details |
| BisindolylMaleiMide X, HCl salt | C26H25ClN4O2 | 1241725-87-0 | Details |
| BMS-2 | C25H16F2N4O3 | 888719-03-7 | Details |
| BMS-3 | Details |
| BMS-5 | Details |
| BMS-599626 | C27H27FN8O3 | 714971-09-2 | Details |
| Brivanib | C19H19FN4O3 | 649735-46-6 | Details |
| Brivanib alaninate | C22H24FN5O4 | 649735-63-7 | Details |
| BS194 | C20H27N5O3 | 1092443-55-4 | Details |
| BX-795 | C23H26IN7O2S | 702675-74-9 | Details |
| BX-912 | C20H23BrN8O | 702674-56-4 | Details |
| Cabozantinib | C28H24FN3O5 | 849217-68-1 | Details |
| Canertinib | C24H25ClFN5O3 | 267243-28-7 | Details |
| CC-401 | C22H24N6O | 395104-30-0 | Details |
| CEP-33779 | C24H26N6O2S | 1346168-57-7 | Details |
| CH5132799 | C15H19N7O3S | 1007207-67-1 | Details |
| CI-1040 | C17H14ClF2IN2O2 | 212631-79-3 | Details |
| CP-724714 | C27H27N5O3 | 383432-38-0 | Details |
| Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
| CX-4945 | C19H12ClN3O2 | 1009820-21-6 | Details |
| CYC-116 | C18H20N6OS | 693228-63-6 | Details |
| Danusertib | C26H30N6O3 | 827318-97-8 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| DianilinopyriMidine_01 | C17H16FN5 | 916603-07-1 | Details |
| diethyl 7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-3,6-dicarboxylate | C12H13N3O5 | 155374-25-7 | Details |
| Dovitinib | C21H21FN6O | 405169-16-6 | Details |
| E7080 | C21H19ClN4O4 | 417716-92-8 | Details |
| Erlotinib Hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
| ethyl 2-(Methylthio)-4-oxo-3,4-dihydropyrazolo[1,5-a][1,3,5]triazine-8-carboxylate | C9H10N4O3S | 278600-53-6 | Details |
| ethyl 3-aMinofuro[2,3-b]pyridine-2-carboxylate | C10H10N2O3 | 371945-06-1 | Details |
| ethyl 3-aMinothieno[2,3-b]pyridine-2-carboxylate | C10H10N2O2S | 52505-46-1 | Details |
| ethyl 3-cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-6-carboxylate | C10H8N4O3 | 64689-83-4 | Details |
| ethyl 5-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H8ClN3O2 | 1224944-77-7 | Details |
| ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H9N3O3 | 926663-00-5 | Details |
| ethyl 7-aMino-5-hydroxypyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H10N4O3 | 90674-09-2 | Details |
| ethyl 7-aMinopyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H10N4O2 | 1196153-97-5 | Details |
| ethyl 7-chloropyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H8ClN3O2 | 749216-54-4 | Details |
| ethyl 7-oxo-4,7-dihydropyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H9N3O3 | 104556-86-7 | Details |
| ethyl pyrazolo[1,5-a]pyriMidine-3-carboxylate | C9H9N3O2 | 115932-00-8 | Details |
| GDC-0941 | C23H27N7O3S2 | 957054-30-7 | Details |
| GDC0980 | C23H30N8O3S | 1032754-93-0 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| GNE 477 | C21H28N8O3S2 | 1032754-81-6 | Details |
| GNE-490 | C18H22N6O2S | 1033739-92-2 | Details |
| GNE-493 | C17H20N6O2S | 1033735-94-2 | Details |
| GPLG0634 | C21H23N5O3S | 1206161-97-8 | Details |
| GSK2126458 | C25H17F2N5O3S | 1086062-66-9 | Details |
| GSK-25 | C24H16Cl2F2N6O | 874119-56-9 | Details |
| GSK690693 | C21H27N7O3 | 937174-76-0 | Details |
| GW441756 | C17H13N3O | 504433-23-2 | Details |
| IC87114 | C22H19N7O | 371242-69-2 | Details |
| IMatinib Mesylate | C30H35N7O4S | 221027-57-1 | Details |
| INK128 | C15H15N7O | 1224844-38-5 | Details |
| Intedanib | C31H33N5O4 | 656247-17-5 | Details |
| isoxazolo[5,4-b]pyridin-3-aMine | C6H5N3O | 92914-74-4 | Details |
| JNJ-28312141 | C26H32N6O2 | 885692-52-4 | Details |
| JNJ-38158471 | C15H17ClN6O3 | 951151-97-6 | Details |
| JNJ38877605 | C19H13F2N7 | 943540-75-8 | Details |
| JNJ7706621 | C15H12F2N6O3S | 443797-96-4 | Details |
| Ki20227 | C24H24N4O5S | 623142-96-1 | Details |
| KU0063794 | C25H31N5O4 | 938440-64-3 | Details |
| KU55933 | C21H17NO3S2 | 587871-26-9 | Details |
| KU57788 | C25H19NO3S | 503468-95-9 | Details |
| Lapatinib | C29H26ClFN4O4S | 231277-92-2 | Details |
| Linifanib | C21H18FN5O | 796967-16-3 | Details |
| LY294002 | C19H17NO3 | 154447-36-6 | Details |
| Masatinib | C28H30N6OS | 790299-79-5 | Details |
| Merck-22-6 | C40H43N7O2 | 12847-42-4 | Details |
| Merck-5 | C18H16FN3O | 457081-03-7 | Details |
| MK-2461 | C24H25N5O5S | 917879-39-1 | Details |
| MoMelotinib | C23H22N6O2 | 1056634-68-4 | Details |
| Motesanib | C22H23N5O | 453562-69-1 | Details |
| Mubritinib | C25H23F3N4O2 | 366017-09-6 | Details |
| Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
| NIBR-17 | C18H20N8O2 | 944396-88-7 | Details |
| Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
| NVP-BGJ398 | C26H31Cl2N7O3 | 872511-34-7 | Details |
| NVP-BSK805 | C27H28F2N6O | 1092499-93-8 | Details |
| Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
| Pazopanib HCl | C21H24ClN7O2S | 635702-64-6 | Details |
| PD0325901 | C16H14F3IN2O4 | 391210-10-9 | Details |
| PD173955 | C21H16Cl2N4OS | 260415-63-2 | Details |
| Purvalanol B | C20H25ClN6O3 | 212844-54-7 | Details |
| PIK-90 | C18H17N5O3 | 677338-12-4 | Details |
| Ponatinib | C29H27F3N6O | 943319-70-8 | Details |
| PIK-294 | C28H23N7O2 | 900185-02-6 | Details |
| PIK-93 | C14H16ClN3O4S2 | 593960-11-3 | Details |
| PHA690509 | C17H21N3O2S | 492445-28-0 | Details |
| PF431396 | C22H21F3N6O3S | 717906-29-1 | Details |
| PIK-75 | C16H14BrN5O4S | 372196-67-3 | Details |
| PF04217903 | C19H16N8O | 956905-27-4 | Details |
| PF-562271 | C21H20F3N7O3S | 717907-75-0 | Details |
| PLX4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
| Pelitinib | C24H23ClFN5O2 | 257933-82-7 | Details |
| PI-103 | C19H16N4O3 | 371935-74-9 | Details |
| PD173955-Analog 1 | C21H14Cl2N4O3 | 185039-99-0 | Details |
| pyrazolo[1,5-a][1,3,5]triazine-2,4-diol | C5H4N4O2 | 34683-40-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||